Abstract PS4-07-30: A Phase II Trial of Ivonescimab in Combination with Carboplatin and Docetaxel in Patients with Early Stage Triple Negative Breast Cancer (TNBC)
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: Y. Yuan, M. Tighiouart, A. Tan, A. Giuliano, S. Karlan, M. Boyle, C. Dang, A. Chung, F. Amersi, P. McAndrew, M. El-Masry, S. Sikaria, D. Chan, S. Valdez, N. Tank, T. Shaw, T. Wang, S. Shiao, S. Merlo, M. Walker, D. Calhoun, G. Park, J. Shen, A. Polverini, A. Terando, D. Lin, Y. Choi, J. Bitar
Institution: Cedars-Sinai Medical Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129331557
Cites:
Cited by:
Related to: